DRUG-COATED BALLOONS HEALTHCARE PROFESSIONALS
Drug Coated Balloon
The IN.PACT™ Admiral™ drug-coated balloon (DCB) is a clinically proven, primary endovascular therapy used to treat femoropopliteal disease.ACCESS PRODUCT OVERVIEW
BEHIND THE OUTCOMES
IN.PACT Admiral DCB increases blood flow and reduces thickening of the artery wall by delivering the proven anti-proliferative drug paclitaxel to the vessel wall.
Average saved on follow-up costs through 2 years per patient with IN.PACT Admiral DCB versus standard PTA2
$2,984 vs. $4,196
Cost savings from the reduced rates of reintervention and higher rates of clinical efficacy make IN.PACT Admiral DCB the clear choice for patients and physicians.
Laird, J. IN.PACT SFA 5-year data presentation, VIVA Congress, Nov. 2018.
Cohen D. Economic Outcomes of Endovascular Femoropopliteal Intervention Using Drug-Coated Balloons vs Standard PTA: 2-Year Results From the IN.PACT SFA II Trial. Presented at: VIVA 15; Nov. 2-5, 2015; Las Vegas.